Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Hypofractionation"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 2267
Tytuł:
Current evidence for moderate and ultra-hypofractionated radiation therapy in prostate cancer: a summary of the results from phase 3 randomised trials.
Autorzy:
Lilleby O; Department of Oncology, Section 5073, Rigshospitalet, Blegdamsvej 9 2100, Copenhagen Ø, Denmark. .
Meidahl Petersen P; Department of Oncology, Copenhagen University Hospital, Copenhagen, Denmark.
Daugaard G; Department of Oncology, Copenhagen University Hospital, Copenhagen, Denmark.
Anne Perell K; Department of Oncology, Copenhagen University Hospital, Copenhagen, Denmark.
Pokaż więcej
Źródło:
Scandinavian journal of urology [Scand J Urol] 2023 Jun 20; Vol. 58, pp. 21-27. Date of Electronic Publication: 2023 Jun 20.
Typ publikacji:
Clinical Trial, Phase III; Randomized Controlled Trial; Journal Article
MeSH Terms:
Radiation Dose Hypofractionation*
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/pathology
Male ; Humans ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Hypofractionated Radiotherapy for Hematologic Malignancies during the COVID-19 Pandemic and Beyond.
Autorzy:
Antony F; Section of Radiation Oncology, Department of Radiology, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.
Dubey A; Section of Radiation Oncology, Department of Radiology, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.
Skrabek P; Section of Medical Oncology/Hematology, Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R3A TR9, Canada.
Tsang LF; Department of Epidemiology, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.
Lambert P; Department of Epidemiology, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.
Bybel B; Section of Nuclear Medicine, Department of Radiology, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.
Ahmed N; Section of Radiation Oncology, Department of Radiology, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.; CancerCare Manitoba Research Institute, Winnipeg, MB R3E 0V9, Canada.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Jan 10; Vol. 31 (1), pp. 383-393. Date of Electronic Publication: 2024 Jan 10.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*
Hematologic Neoplasms*/radiotherapy
Humans ; Radiation Dose Hypofractionation ; Pandemics ; Prospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): a non-inferiority, open-label, phase III randomised trial.
Autorzy:
Yadav BS; Department of Radiotherapy & Oncology, Post Graduate Institute of Medical Education & Research, Chandigarh, India. .
Dahiya D; Department of General Surgery, Post Graduate Institute of Medical Education & Research, Chandigarh, India.
Kannan P; Department of Radiotherapy & Oncology, Post Graduate Institute of Medical Education & Research, Chandigarh, India.
Goyal S; Department of Radiotherapy & Oncology, Post Graduate Institute of Medical Education & Research, Chandigarh, India.
Laroiya I; Department of General Surgery, Post Graduate Institute of Medical Education & Research, Chandigarh, India.
Irrinki S; Department of General Surgery, Post Graduate Institute of Medical Education & Research, Chandigarh, India.
Singh NR; Department of Radiotherapy & Oncology, Post Graduate Institute of Medical Education & Research, Chandigarh, India.
Sharma R; Department of Radiotherapy & Oncology, Post Graduate Institute of Medical Education & Research, Chandigarh, India.
Pokaż więcej
Źródło:
Trials [Trials] 2024 Jan 02; Vol. 25 (1), pp. 21. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Clinical Trial, Phase III; Randomized Controlled Trial; Journal Article
MeSH Terms:
Breast Neoplasms*/radiotherapy
Breast Neoplasms*/surgery
Neoplasms, Second Primary*/complications
Neoplasms, Second Primary*/surgery
Radiation Injuries*/etiology
Humans ; Female ; Radiation Dose Hypofractionation ; Radiotherapy, Adjuvant/adverse effects ; Radiotherapy, Adjuvant/methods ; Mastectomy/adverse effects ; Quality of Life ; Treatment Outcome ; Neoplasm Recurrence, Local/pathology ; Adjuvants, Immunologic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The impact of the COVID-19 pandemic on radiotherapy delivery in Japan: An observational study based on the national database.
Autorzy:
Tamari K; Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
Kishigami M; Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
Nagata Y; Department of Radiation Oncology, Hiroshima University Hospital, Hiroshima, Japan.
Mizowaki T; Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Kodaira T; Department of Radiation Oncology, Aichi Cancer Center Hospital, Aichi, Japan.
Onishi H; Department of Radiology, University of Yamanashi School of Medicine, Yamanashi, Japan.
Ogawa K; Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
Shioyama Y; Ion Beam Therapy Center, SAGA-HIMAT Foundation, Saga, Japan.
Shigematsu N; Department of Radiology, Keio University School of Medicine, Tokyo, Japan.
Uno T; Department of Radiology, Chiba University Graduate School of Medicine, Chiba, Japan.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Nov; Vol. 12 (22), pp. 21032-21040. Date of Electronic Publication: 2023 Oct 30.
Typ publikacji:
Observational Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Pandemics*
COVID-19*/epidemiology
Male ; Humans ; Japan/epidemiology ; Radiation Dose Hypofractionation ; Prostate-Specific Antigen
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The impact of short-course hypofractionated radiotherapy on multimodality treatment utilisation, compliance, and outcome in glioblastoma patients: a Danish patterns of care study.
Autorzy:
Vamsi VS; Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Lukacova S; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
Dahlrot RH; Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.; Department of Oncology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Guldberg TL; Department of Oncology, Aalborg University Hospital, Aalborg, Denmark.
Korshøj AR; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Neurosurgery, Aarhus University Hospital, Aarhus, Denmark.
Muhic A; Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.; Department of Oncology, Copenhagen University Hospital, Copenhagen, Denmark.
Trip AK; Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Nov; Vol. 62 (11), pp. 1511-1519. Date of Electronic Publication: 2023 Aug 09.
Typ publikacji:
Journal Article
MeSH Terms:
Glioblastoma*/therapy
Adult ; Humans ; Retrospective Studies ; Radiation Dose Hypofractionation ; Dose Fractionation, Radiation ; Denmark ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Phase 1/2 trial evaluating the effectiveness and safety of dose-adapted Hypofractionated pelvic radiotherapy for Advanced Cervical cancers INeligible for ChemoTherapy (HYACINCT).
Autorzy:
Bacorro W; Department of Radiation Oncology, University of Santo Tomas Hospital - Benavides Cancer Institute, Manila, Philippines.
Baldivia K; Department of Radiation Oncology, University of Santo Tomas Hospital - Benavides Cancer Institute, Manila, Philippines.
Dumago M; Department of Radiation Oncology, University of Santo Tomas Hospital - Benavides Cancer Institute, Manila, Philippines.
Bojador M; Department of Radiation Oncology, University of Santo Tomas Hospital - Benavides Cancer Institute, Manila, Philippines.
Milo A; Department of Radiology, University of Santo Tomas Hospital, Manila, Philippines.
Trinidad CM; Department of Anatomic Pathology, University of Santo Tomas Hospital, Manila, Philippines.
Mariano J; Gynecologic Oncology Unit, University of Santo Tomas Hospital - Benavides Cancer Institute, Manila, Philippines.
Gonzalez G; Gynecologic Oncology Unit, University of Santo Tomas Hospital - Benavides Cancer Institute, Manila, Philippines.
Sy Ortin T; Department of Radiation Oncology, University of Santo Tomas Hospital - Benavides Cancer Institute, Manila, Philippines.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2022 Jun; Vol. 61 (6), pp. 688-697. Date of Electronic Publication: 2022 Mar 14.
Typ publikacji:
Clinical Trial, Phase I; Clinical Trial, Phase II; Letter
MeSH Terms:
Radiation Dose Hypofractionation*
Radiotherapy, Intensity-Modulated*/adverse effects
Radiotherapy, Intensity-Modulated*/methods
Uterine Cervical Neoplasms*/pathology
Uterine Cervical Neoplasms*/radiotherapy
Adult ; Brachytherapy ; Chemoradiotherapy ; Female ; Humans
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Dosimetric effect of respiratory motion on planned dose in whole-breast volumetric modulated arc therapy using moderate and ultra-hypofractionation.
Autorzy:
Mankinen M; Department of Physics, University of Jyväskylä (JYU), P.O. Box 35, FI-40014, Jyväskylä, Finland. .; Department of Medical Physics, Central Finland Health Care District, Hoitajantie 3, FI-40620, Jyväskylä, Finland. .
Virén T; Center of Oncology, Kuopio University Hospital (KUH), Kuopio, Finland.
Seppälä J; Center of Oncology, Kuopio University Hospital (KUH), Kuopio, Finland.
Hakkarainen H; Department of Medical Physics, Central Finland Health Care District, Hoitajantie 3, FI-40620, Jyväskylä, Finland.
Koivumäki T; Department of Physics, University of Jyväskylä (JYU), P.O. Box 35, FI-40014, Jyväskylä, Finland.; Department of Medical Physics, Central Finland Health Care District, Hoitajantie 3, FI-40620, Jyväskylä, Finland.
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2022 Mar 05; Vol. 17 (1), pp. 46. Date of Electronic Publication: 2022 Mar 05.
Typ publikacji:
Journal Article
MeSH Terms:
Radiation Dose Hypofractionation*
Lung Neoplasms/*radiotherapy
Radiotherapy, Intensity-Modulated/*methods
Humans ; Radiometry ; Radiotherapy Dosage ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Unwarranted variation in radiation therapy fractionation.
Autorzy:
Batumalai V; Collaboration for Cancer Outcomes, Research and Evaluation, Ingham Institute for Applied Medical Research, South Western Clinical School, University of New South Wales, Sydney, New South Wales, Australia.; GenesisCare, Sydney, New South Wales, Australia.
James M; Christchurch Oncology Service, Canterbury Regional Cancer and Haematology Centre, Christchurch, New Zealand.; Department of Medicine, Christchurch Hospital, University of Otago Christchurch, Christchurch, New Zealand.
Pokaż więcej
Źródło:
Journal of medical imaging and radiation oncology [J Med Imaging Radiat Oncol] 2022 Mar; Vol. 66 (2), pp. 233-241.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Delivery of Health Care*
Radiation Dose Hypofractionation*
Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Patient-related risk factors for late rectal bleeding after hypofractionated radiotherapy for localized prostate cancer: a single-center retrospective study.
Autorzy:
Kim TG; Department of Radiation Oncology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, 630-522, South Korea. .
Park B; Department of Radiation Oncology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, 630-522, South Korea.
Song YG; Department of Radiology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, 630-522, South Korea.
Lee HW; Department of Pathology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, 630-522, South Korea.
Oh TH; Department of Urology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, 630-522, South Korea.
Ryu DS; Department of Urology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, 630-522, South Korea.
Jeong SC; Department of Urology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, 630-522, South Korea.
Cho D; Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, 630-522, South Korea.
Oh J; Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, 630-522, South Korea.
Kim KM; Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, 630-522, South Korea.
Lee JW; Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, 630-522, South Korea.
Lee HS; Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, 630-522, South Korea.
Kong SM; Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, 630-522, South Korea.
Kim JY; Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, 630-522, South Korea.
Kim H; Departments of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, South Korea.
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2022 Feb 09; Vol. 17 (1), pp. 30. Date of Electronic Publication: 2022 Feb 09.
Typ publikacji:
Journal Article
MeSH Terms:
Radiation Dose Hypofractionation*
Hemorrhage/*etiology
Prostatic Neoplasms/*radiotherapy
Radiation Injuries/*etiology
Aged ; Aged, 80 and over ; Hemorrhage/epidemiology ; Humans ; Male ; Middle Aged ; Prostatic Neoplasms/pathology ; Radiation Injuries/epidemiology ; Rectum ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Outcomes of hypofractionation for early-stage glottic carcinoma.
Autorzy:
Uysal B; Department of Radiation Oncology, Gulhane Medical Faculty, University of Health Sciences, Ankara, Turkey.
Gamsiz H
Colak O
Beyzadeoglu M
Pokaż więcej
Źródło:
Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Oct 01; Vol. 19 (7), pp. 1962-1966. Date of Electronic Publication: 2023 Apr 26.
Typ publikacji:
Journal Article
MeSH Terms:
Laryngeal Neoplasms*/radiotherapy
Carcinoma*
Humans ; Radiation Dose Hypofractionation ; Disease-Free Survival ; Dose Fractionation, Radiation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Variability of α/β ratios for prostate cancer with the fractionation schedule: caution against using the linear-quadratic model for hypofractionated radiotherapy.
Autorzy:
Cui M; Department of Radiation Oncology, Peking University First Hospital, Peking University, Beijing, People's Republic of China.; Department of Radiation Oncology Gastrointestinal and Urinary and Musculoskeletal Cancer, Cancer Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.
Gao XS; Department of Radiation Oncology, Peking University First Hospital, Peking University, Beijing, People's Republic of China. .
Li X; Department of Radiation Oncology, Peking University First Hospital, Peking University, Beijing, People's Republic of China.
Ma M; Department of Radiation Oncology, Peking University First Hospital, Peking University, Beijing, People's Republic of China.
Qi X; Department of Radiation Oncology, Peking University First Hospital, Peking University, Beijing, People's Republic of China.
Shibamoto Y; Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, 467-8601, Japan. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2022 Mar 18; Vol. 17 (1), pp. 54. Date of Electronic Publication: 2022 Mar 18.
Typ publikacji:
Journal Article
MeSH Terms:
Linear Models*
Radiation Dose Hypofractionation*
Prostatic Neoplasms/*radiotherapy
Humans ; Male
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Simultaneous integrated boost (SIB) to dominant intra-prostatic lesions during extreme hypofractionation for prostate cancer: the impact of rectal spacers.
Autorzy:
Osman SOS; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, BT7 1NN, Northern Ireland, UK. .; Radiotherapy Physics, Northern Ireland Cancer Centre, Belfast Health and Social Care Trust, Belfast, UK. .
Fairmichael C; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, BT7 1NN, Northern Ireland, UK.; Clinical Oncology, Northern Ireland Cancer Centre, Belfast Health and Social Care Trust, Belfast, UK.
Whitten G; Radiotherapy Physics, Northern Ireland Cancer Centre, Belfast Health and Social Care Trust, Belfast, UK.
Lundy GS; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, BT7 1NN, Northern Ireland, UK.
Wesselman R; Radiotherapy Physics, Northern Ireland Cancer Centre, Belfast Health and Social Care Trust, Belfast, UK.
Wilson ML; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, BT7 1NN, Northern Ireland, UK.
Hounsell AR; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, BT7 1NN, Northern Ireland, UK.; Radiotherapy Physics, Northern Ireland Cancer Centre, Belfast Health and Social Care Trust, Belfast, UK.
Prise KM; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, BT7 1NN, Northern Ireland, UK.
Irvine D; Radiotherapy Physics, Northern Ireland Cancer Centre, Belfast Health and Social Care Trust, Belfast, UK.
McGarry CK; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, BT7 1NN, Northern Ireland, UK.; Radiotherapy Physics, Northern Ireland Cancer Centre, Belfast Health and Social Care Trust, Belfast, UK.
Jain S; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, BT7 1NN, Northern Ireland, UK.; Clinical Oncology, Northern Ireland Cancer Centre, Belfast Health and Social Care Trust, Belfast, UK.
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2022 Feb 22; Vol. 17 (1), pp. 38. Date of Electronic Publication: 2022 Feb 22.
Typ publikacji:
Journal Article
MeSH Terms:
Radiation Dose Hypofractionation*
Adenocarcinoma/*radiotherapy
Prostatic Neoplasms/*radiotherapy
Radiosurgery/*instrumentation
Radiotherapy, Intensity-Modulated/*instrumentation
Humans ; Male ; Rectum
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Safety of accelerated hypofractionated whole pelvis radiation therapy prior to high dose rate brachytherapy or stereotactic body radiation therapy prostate boost.
Autorzy:
Phuong C; Department of Radiation Oncology, University of California San Francisco, San Francisco, USA.
Chan JW; Department of Radiation Oncology, University of California San Francisco, San Francisco, USA.
Ni L; Department of Radiation Oncology, University of California San Francisco, San Francisco, USA.
Wall P; Department of Radiation Oncology, University of California San Francisco, San Francisco, USA.
Mohamad O; Department of Radiation Oncology, University of California San Francisco, San Francisco, USA.
Wong AC; Department of Radiation Oncology, University of California San Francisco, San Francisco, USA.
Hsu IC; Department of Radiation Oncology, University of California San Francisco, San Francisco, USA.
Chang AJ; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, USA. .; UCLA Radiation Oncology, 200 Medical Plaza Suite B265, Los Angeles, CA, 90024, USA. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2022 Jan 20; Vol. 17 (1), pp. 12. Date of Electronic Publication: 2022 Jan 20.
Typ publikacji:
Journal Article
MeSH Terms:
Brachytherapy*
Radiation Dose Hypofractionation*
Radiosurgery*
Prostatic Neoplasms/*radiotherapy
Aged ; Humans ; Male ; Radiotherapy Dosage ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Dosimetric evaluation of photons versus protons in postmastectomy planning for ultrahypofractionated breast radiotherapy.
Autorzy:
Oonsiri P; Division of Radiation Oncology, Department of Radiology, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand.
Nantavithya C; Division of Radiation Oncology, Department of Radiology, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand.; Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Lertbutsayanukul C; Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Sarsitthithum T; Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Vimolnoch M; Division of Radiation Oncology, Department of Radiology, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand.
Tawonwong T; Division of Radiation Oncology, Department of Radiology, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand.
Saksornchai K; Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2022 Jan 29; Vol. 17 (1), pp. 20. Date of Electronic Publication: 2022 Jan 29.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Proton Therapy*
Radiation Dose Hypofractionation*
Breast Neoplasms/*radiotherapy
Photons/*therapeutic use
Radiotherapy, Intensity-Modulated/*methods
Breast Neoplasms/surgery ; Combined Modality Therapy ; Female ; Humans ; Mastectomy ; Radiometry ; Radiotherapy Dosage
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Differential effects of radiation fractionation regimens on glioblastoma.
Autorzy:
McKelvey KJ; Bill Walsh Translational Cancer Research Laboratory, Faculty of Medicine and Health, The University of Sydney, St Leonards, NSW, 2065, Australia. .
Hudson AL; Bill Walsh Translational Cancer Research Laboratory, Faculty of Medicine and Health, The University of Sydney, St Leonards, NSW, 2065, Australia.
Donaghy H; Bill Walsh Translational Cancer Research Laboratory, Faculty of Medicine and Health, The University of Sydney, St Leonards, NSW, 2065, Australia.
Stoner SP; Bill Walsh Translational Cancer Research Laboratory, Faculty of Medicine and Health, The University of Sydney, St Leonards, NSW, 2065, Australia.
Wheeler HR; Bill Walsh Translational Cancer Research Laboratory, Faculty of Medicine and Health, The University of Sydney, St Leonards, NSW, 2065, Australia.; Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW, 2065, Australia.; Department of Medical Oncology, Royal North Shore Hospital, St Leonards, NSW, 2065, Australia.
Diakos CI; Bill Walsh Translational Cancer Research Laboratory, Faculty of Medicine and Health, The University of Sydney, St Leonards, NSW, 2065, Australia.; Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW, 2065, Australia.; Department of Medical Oncology, Royal North Shore Hospital, St Leonards, NSW, 2065, Australia.
Howell VM; Bill Walsh Translational Cancer Research Laboratory, Faculty of Medicine and Health, The University of Sydney, St Leonards, NSW, 2065, Australia.
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2022 Jan 25; Vol. 17 (1), pp. 17. Date of Electronic Publication: 2022 Jan 25.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Radiation Dose Hypofractionation*
Antineoplastic Agents, Alkylating/*therapeutic use
Glioblastoma/*drug therapy
Glioblastoma/*radiotherapy
Temozolomide/*therapeutic use
Animals ; Mice ; Radiotherapy/methods ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer.
Autorzy:
Zhang Q; Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, 241 West Huaihai Road, Shanghai, 200030, China. .
Cai XW; Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, 241 West Huaihai Road, Shanghai, 200030, China.
Feng W; Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, 241 West Huaihai Road, Shanghai, 200030, China.
Yu W; Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, 241 West Huaihai Road, Shanghai, 200030, China.
Fu XL; Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, 241 West Huaihai Road, Shanghai, 200030, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2022 Jan 22; Vol. 22 (1), pp. 96. Date of Electronic Publication: 2022 Jan 22.
Typ publikacji:
Clinical Trial; Journal Article
MeSH Terms:
Radiation Dose Hypofractionation*
Carcinoma, Non-Small-Cell Lung/*therapy
Lung Neoplasms/*therapy
Radiotherapy Planning, Computer-Assisted/*methods
Radiotherapy, Intensity-Modulated/*methods
Adult ; Aged ; Antineoplastic Agents/therapeutic use ; Carcinoma, Non-Small-Cell Lung/pathology ; Chemoradiotherapy ; Cisplatin/therapeutic use ; Docetaxel/therapeutic use ; Female ; Humans ; Lung Neoplasms/pathology ; Male ; Maximum Tolerated Dose ; Middle Aged ; Neoplasm Staging ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trial.
Autorzy:
Elbers JBW; Department of Radiotherapy, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. .; Department of Radiotherapy, HollandPTC, Delft, The Netherlands. .
Gunsch PA; Department of Radiotherapy, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Debets R; Department of Medical Oncology, Laboratory of Tumor Immunology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Keereweer S; Department of Otorhinolaryngology head and neck surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
van Meerten E; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Zindler J; Department of Radiotherapy, HollandPTC, Delft, The Netherlands.; Department of Radiotherapy, Haaglanden Medical Center, Den Haag, The Netherlands.
van Norden Y; Department of Radiotherapy, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Hoogeman MS; Department of Radiotherapy, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Radiotherapy, HollandPTC, Delft, The Netherlands.
Verduijn GM; Department of Radiotherapy, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Kroesen M; Department of Radiotherapy, HollandPTC, Delft, The Netherlands.
Nout RA; Department of Radiotherapy, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Jun 13; Vol. 23 (1), pp. 541. Date of Electronic Publication: 2023 Jun 13.
Typ publikacji:
Journal Article
MeSH Terms:
Photons*
Head and Neck Neoplasms*/radiotherapy
Humans ; Protons ; Radiation Dose Hypofractionation ; Squamous Cell Carcinoma of Head and Neck/radiotherapy ; Immunosuppression Therapy ; Multicenter Studies as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The efficacy and tolerability of ultra-hypofractionated radiotherapy in low-intermediate risk prostate cancer patients: single center experience.
Autorzy:
Dinçer S; Department of Radiation Oncology, University of Health Science Prof. Dr. CemilTascioglu City Hospital, Istanbul, Turkey.
Uysal E; Department of Radiation Oncology, University of Health Science Prof. Dr. CemilTascioglu City Hospital, Istanbul, Turkey.
Berber T; Department of Radiation Oncology, University of Health Science Prof. Dr. CemilTascioglu City Hospital, Istanbul, Turkey.
Akboru MH; Department of Radiation Oncology, University of Health Science Prof. Dr. CemilTascioglu City Hospital, Istanbul, Turkey.
Pokaż więcej
Źródło:
The aging male : the official journal of the International Society for the Study of the Aging Male [Aging Male] 2021 Dec; Vol. 24 (1), pp. 50-57.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Neoplasms*/radiotherapy
Radiation Dose Hypofractionation*
Aged ; Aged, 80 and over ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparison of hypofractionation and standard fractionation for post-prostatectomy salvage radiotherapy in patients with persistent PSA: single institution experience.
Autorzy:
Murgic J; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Vinogradska 29, 10000, Zagreb, Croatia.
Jaksic B; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Vinogradska 29, 10000, Zagreb, Croatia.
Prpic M; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Vinogradska 29, 10000, Zagreb, Croatia.; School of Dental Medicine, University of Zagreb, Gunduliceva 5, 10000, Zagreb, Croatia.
Kust D; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Vinogradska 29, 10000, Zagreb, Croatia.
Bahl A; University Hospitals Bristol NHS Foundation Trust, Marlborough Street, Bristol, BS13NU, UK.
Budanec M; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Vinogradska 29, 10000, Zagreb, Croatia.
Prgomet Secan A; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Vinogradska 29, 10000, Zagreb, Croatia.
Franco P; Department of Translational Medicine, University of Eastern Piedmont, 28100, Novara, Italy.; Department of Radiation Oncology, 'Maggiore della Carità' University Hospital, 28100, Novara, Italy.
Kruljac I; Department of Endocrinology, Diabetes and Metabolic Diseases 'Mladen Sekso', University Hospital Center Sestre Milosrdnice, University of Zagreb School of Medicine, Vinogradska 29, 10000, Zagreb, Croatia.
Spajic B; Department of Urology, University Hospital Center Sestre Milosrdnice, 10000, Zagreb, Croatia.
Babic N; Department of Radiology, University Hospital Center Sestre Milosrdnice, Vinogradska 29, 10000, Zagreb, Croatia.
Kruslin B; Ljudevit Jurak Department of Pathology and Cytology, Sestre Milosrdnice University Hospital Centre, Vinogradska 29, 10000, Zagreb, Croatia.
Zovak M; Department of Surgery, University Hospital Center Sestre Milosrdnice, Vinogradska 29, 10000, Zagreb, Croatia.
Zubizarreta E; Division of Human Health, International Atomic Energy Agency (IAEA), Wagramer Str. 5, 1220, Vienna, Austria.
Rosenblatt E; Division of Human Health, International Atomic Energy Agency (IAEA), Wagramer Str. 5, 1220, Vienna, Austria.
Fröbe A; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Vinogradska 29, 10000, Zagreb, Croatia. .; School of Dental Medicine, University of Zagreb, Gunduliceva 5, 10000, Zagreb, Croatia. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2021 May 12; Vol. 16 (1), pp. 88. Date of Electronic Publication: 2021 May 12.
Typ publikacji:
Clinical Trial; Comparative Study; Journal Article
MeSH Terms:
Dose Fractionation, Radiation*
Radiation Dose Hypofractionation*
Salvage Therapy*
Prostate-Specific Antigen/*blood
Prostatectomy/*mortality
Prostatic Neoplasms/*mortality
Radiotherapy, Intensity-Modulated/*mortality
Aged ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/mortality ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/radiotherapy ; Neoplasm Recurrence, Local/surgery ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/radiotherapy ; Prostatic Neoplasms/surgery ; Radiotherapy, Intensity-Modulated/methods ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 2267

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies